Inducible ablation of astrocytes shows that these cells are required for neuronal survival in the adult brain

被引:118
作者
Cui, W
Allen, ND
Skynner, M
Gusterson, B
Clark, AJ [1 ]
机构
[1] Roslin Inst, Div Gene Express & Dev, Roslin EH25 9PS, Midlothian, Scotland
[2] Babraham Inst, Lab Cognit & Dev Neurosci, Cambridge, England
[3] Univ Glasgow, Dept Pathol, Glasgow G12 8QQ, Lanark, Scotland
关键词
Bergmann glia; CB1954; cerebellum; nitroreductase; glutamate transporter; transgenic;
D O I
10.1002/glia.1061
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
To study the function of astrocytes in the adult brain, we have targeted the expression of E. coli nitroreductase (NTR) to the astrocytes of transgenic mice under the control of the GFAP promoter. The astrocytes expressing NTR were selectively ablated after administration of the prodrug CB1954, resulting in motor discoordination. Histological examination showed that the region most affected in the brain was the cerebellum, in which the Bergmann glia were eliminated and the granular neurons had degenerated. Specific effects were also noted on the dendrites of the Purkinje cells, and the junction between these neurons and granular layer was disrupted. Astrocyte ablation was associated with a dramatic decrease in the expression of glutamate transporters, which may account for the degeneration of granular neurons since the excitotoxic effects of glutamate result in a similar phenotype. These results provide the first evidence that astrocytes are important for the survival of neurons in the adult brain in vivo. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:272 / 282
页数:11
相关论文
共 36 条
  • [1] THE BIOACTIVATION OF 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE (CB1954) .1. PURIFICATION AND PROPERTIES OF A NITROREDUCTASE ENZYME FROM ESCHERICHIA-COLI - A POTENTIAL ENZYME FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT)
    ANLEZARK, GM
    MELTON, RG
    SHERWOOD, RF
    COLES, B
    FRIEDLOS, F
    KNOX, RJ
    [J]. BIOCHEMICAL PHARMACOLOGY, 1992, 44 (12) : 2289 - 2295
  • [2] CELL-CELL INTERACTIONS INFLUENCE SURVIVAL AND DIFFERENTIATION OF PURIFIED PURKINJE-CELLS IN-VITRO
    BAPTISTA, CA
    HATTEN, ME
    BLAZESKI, R
    MASON, CA
    [J]. NEURON, 1994, 12 (02) : 243 - 260
  • [3] The bystander effect of the nitroreductase CB 1954 enzyme prodrug system is due to a cell-permeable metabolite
    Bridgewater, JA
    Knox, RJ
    Pitts, JD
    Collins, MK
    Springer, CJ
    [J]. HUMAN GENE THERAPY, 1997, 8 (06) : 709 - 717
  • [4] Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice
    Bush, TG
    Puvanachandra, N
    Horner, CH
    Polito, A
    Ostenfeld, T
    Svendsen, CN
    Mucke, L
    Johnson, MH
    Sofroniew, MV
    [J]. NEURON, 1999, 23 (02) : 297 - 308
  • [5] Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice
    Bush, TG
    Savidge, TC
    Freeman, TC
    Cox, HJ
    Campbell, EA
    Mucke, L
    Johnson, MH
    Sofroniew, MV
    [J]. CELL, 1998, 93 (02) : 189 - 201
  • [6] Selective cell ablation in transgenic mice expressing E-coli nitroreductase
    Clark, AJ
    Iwobi, M
    Cui, W
    Crompton, M
    Harold, G
    Hobbs, S
    Kamalati, T
    Knox, R
    Neil, C
    Yull, F
    Gusterson, B
    [J]. GENE THERAPY, 1997, 4 (02) : 101 - 110
  • [7] Nitroreductase-mediated cell ablation is very rapid and mediated by a p53-independent apoptotic pathway
    Cui, W
    Gusterson, B
    Clark, AJ
    [J]. GENE THERAPY, 1999, 6 (05) : 764 - 770
  • [8] Delaney CL, 1996, J NEUROSCI, V16, P6908
  • [9] Variegated transgene expression in mouse mammary gland is determined by the transgene integration locus
    Dobie, KW
    Lee, M
    Fantes, JA
    Graham, E
    Clark, AJ
    Springbett, A
    Lathe, R
    McClenaghan, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (13) : 6659 - 6664
  • [10] The expression of bacterial nitroreductase in transgenic mice results in specific cell killing by the prodrug CB1954
    Drabek, D
    Guy, J
    Craig, R
    Grosveld, F
    [J]. GENE THERAPY, 1997, 4 (02) : 93 - 100